757 top medical experts on Thrombotic Thrombocytopenic Purpura across 37 countries and 37 U.S. states, including 671 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Thrombotic Thrombocytopenic Purpura: An acquired, congenital, or familial disorder caused by platelet aggregation with thrombosis in terminal arterioles and capillaries. Clinical features include thrombocytopenia; hemolytic anemia; azotemia; fever; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as renal failure. Mutations in the adamts13 protein gene have been identified in familial cases.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Thrombocytopenic Purpura (453), Thrombophilia (2,217).
  4. Clinical Trials ClinicalTrials.gov : at least 46 including 1 Active, 15 Completed, 10 Recruiting
  5. Synonyms: Moschkowitz Disease,  Thrombotic Thrombopenic Purpura,  Congenital Thrombotic Thrombocytopenic Purpura,  Familial Thrombotic Thrombocytopenic Purpura


  

        

                    


    Computing Expert Listing ...

);